About
Cleara Biotech is a biopharmaceutical R&D company developing peptide-based therapeutics that selectively eliminate cancer cells with impaired p53 signaling, focusing on solid tumors and hematological malignancies.
Explore Cleara Biotech B.V.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.